MBA MSc - Saniona AB CoFounder CEO

All Insiders . Sweden . 
Stock . Saniona AB . Stakeholders . Insider . MBA MSc
SANION Stock  SEK 7.75  0.11  1.40%   

Insider

MBA MSc is CoFounder CEO of Saniona AB
Age 63
Phone45 70 70 52 25
Webhttps://www.saniona.com

Saniona AB Management Efficiency

The company has return on total asset (ROA) of (0.5044) % which means that it has lost $0.5044 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.3844) %, meaning that it generated substantial loss on money invested by shareholders. Saniona AB's management efficiency ratios could be used to measure how well Saniona AB manages its routine affairs as well as how well it operates its assets and liabilities.
Saniona AB has accumulated 92.97 M in total debt with debt to equity ratio (D/E) of 34.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Saniona AB has a current ratio of 1.26, suggesting that it may have difficulties to pay its financial obligations in time and when they become due. Debt can assist Saniona AB until it has trouble settling it off, either with new capital or with free cash flow. So, Saniona AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Saniona AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Saniona to invest in growth at high rates of return. When we think about Saniona AB's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Klaus SindahlHansa Biopharma AB
N/A
Thomas PfisterGomSpace Group AB
47
Jens MDZealand Pharma AS
N/A
Katja MargellHansa Biopharma AB
N/A
Sren MScHansa Biopharma AB
58
Brge WitthftGomSpace Group AB
71
Emanuel BjrneHansa Biopharma AB
50
Ravinder ChahilZealand Pharma AS
N/A
Adam MDZealand Pharma AS
49
Ivan MollerZealand Pharma AS
51
Stefan MBABioInvent International AB
60
Sylvie RyckebuschBioInvent International AB
N/A
Hanne BakZealand Pharma AS
70
Anne LannerHansa Biopharma AB
54
Bjrn FrendusBioInvent International AB
50
Cecilia HofvanderBioInvent International AB
56
Christina BredalZealand Pharma AS
38
Danilo VergeZealand Pharma AS
N/A
Eduardo CruzGomSpace Group AB
40
Mads KronborgZealand Pharma AS
N/A
Henriette WennickeZealand Pharma AS
N/A
Saniona AB , a research and development company, engages in the development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases, and treatment of pain in Denmark. Saniona AB was founded in 2011 and is headquartered in Ballerup, Denmark. Saniona AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 21 people. Saniona AB (SANION) is traded on Stockholm Exchange in Sweden and employs 25 people.

Management Performance

Return On Equity-1.38
Return On Asset-0.5

Saniona AB Leadership Team

Elected by the shareholders, the Saniona AB's board of directors comprises two types of representatives: Saniona AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Saniona. The board's role is to monitor Saniona AB's management team and ensure that shareholders' interests are well served. Saniona AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Saniona AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
Karin Nielsen, Chief Officer
Rami Levin, President
Palle MS, Ex Research
Anita BCom, Chief Officer
Janus Larsen, Chief Officer
MBA MSc, CoFounder CEO
Jorgen Drejer, Chairman Founder

Saniona Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Saniona AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-1.38
Return On Asset-0.5
Operating Margin(19.74) %
Current Valuation155.94 M
Shares Outstanding62.39 M
Shares Owned By Insiders22.91 %
Shares Owned By Institutions20.60 %
Price To Earning(176.87) X
Price To Book2.10 X
Price To Sales12.55 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in Saniona Stock

Saniona AB financial ratios help investors to determine whether Saniona Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Saniona with respect to the benefits of owning Saniona AB security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY